Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study to Assess the Safety and Anti-tumour Activity of Dexanabinol Monotherapy and Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

NCT02423239 is registered in ClinicalTrials.gov with e-Therapeutics PLC as lead sponsor.

NCT NCT02423239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02423239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study to Assess the Safety and Anti-tumour Activity of Dexanabinol Monotherapy and Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
Lead sponsor
e-Therapeutics PLC
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2015
Completion date
December 31, 2016
Enrollment
112 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, pancreatic cancer